Rallybio (RLYB) Other financing activities (2021 - 2025)
Rallybio (RLYB) posted Other financing activities of $6000.0 for Q4 2025, down 66.67% sequentially from $18000.0 in Q4 2024, and down 66.67% YoY from $18000.0 in Q4 2024.
Rallybio (RLYB) Other financing activities (2021 - 2025) Analysis & Trends
Rallybio has reported Other financing activities for 5 years, with the latest figure at $6000.0 in Q4 2025.
- Quarterly Other financing activities fell 66.67% year-over-year to $6000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24000.0 (down 73.63% YoY) and the FY2025 annual result came in at $16000.0, down 74.19% from the prior year.
- Other financing activities eased to $6000.0 in Q4 2025 per RLYB's latest filing, from $18000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $217000.0 in Q4 2022 and troughed at -$86.2 million in Q4 2021.
- A 5-year average of -$17.2 million and a median of $18000.0 in 2024 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2022 and 2024: Other financing activities surged 100.25% in 2022, then sank 75.34% in 2024.
- Over 5 years, Other financing activities stood at -$86.2 million in 2021, then jumped by 100.25% to $217000.0 in 2022, then plunged by 66.36% to $73000.0 in 2023, then tumbled by 75.34% to $18000.0 in 2024, then slumped by 66.67% to $6000.0 in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered $6000.0, $18000.0, and $73000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Rallybio | 94.61 Mn | 94.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Dec 31, 2022 | 217,000.00 |
| Dec 31, 2022 | 217,000.00 |
| Dec 31, 2021 | -86.20 Mn |
| Dec 31, 2021 | -86.20 Mn |